Thiopurine S-methyltransferase genetic polymorphism in the Thai population

被引:37
作者
Srimartpirom, S
Tassaneeyakul, W [1 ]
Kukongviriyapan, V
Tassaneeyakul, W [1 ]
机构
[1] Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen 40002, Thailand
[2] Khon Kaen Univ, Fac Pharmaceut Sci, Dept Toxicol, Khon Kaen 40002, Thailand
关键词
genetic polymorphism; Thai; thiopurine S-methyltransferase; TPMT;
D O I
10.1111/j.1365-2125.2004.02112.x
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Aims To determine the incidence of the thiopurine S-methyltransferase (TPMT) genetic polymorphism in the Thai population. Methods Genomic DNAs were isolated from peripheral blood leucocytes of 200 healthy Thais. The frequencies of five allelic variants of the TPMT gene, TPMT*2, *3A, *3B, *3C and *6 were determined using allele specific polymerase chain reaction (PCR) or PCR-Restriction fragment length polymorphism technique. Results Of the 200 Thai subjects participating in this study, 181 subjects (90.5%) were homozygous for TPMT*1, 18 subjects (9.0%) were heterozygous for TPMT*1/*3C. Only one subject (0.5%) was homozygous for TPMT*3C. The frequency of TPMT*3C mutant allele was 0.050. Conclusions Although the TPMT*3C is the most prevalent mutant allele in Asian populations, the frequency of this defective allele is significantly higher in Thais than has been reported in other Asian populations.
引用
收藏
页码:66 / 70
页数:5
相关论文
共 27 条
[1]
Thiopurine methyltransferase alleles in British and Ghanaian populations [J].
Ameyaw, MM ;
Collie-Duguid, ESR ;
Powrie, RH ;
Ofori-Adjei, D ;
McLeod, HL .
HUMAN MOLECULAR GENETICS, 1999, 8 (02) :367-370
[2]
Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia [J].
Ando, M ;
Ando, Y ;
Hasegawa, Y ;
Sekido, Y ;
Shimokata, K ;
Horibe, K .
PHARMACOGENETICS, 2001, 11 (03) :269-273
[3]
Photoluminescence excitation spectroscopy obtained for spark-processed Si [J].
Chang, SS .
APPLIED SURFACE SCIENCE, 2002, 191 (1-4) :5-10
[4]
The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations [J].
Collie-Duguid, ESR ;
Pritchard, SC ;
Powrie, RH ;
Sludden, J ;
Collier, DA ;
Li, T ;
McLeod, HL .
PHARMACOGENETICS, 1999, 9 (01) :37-42
[5]
Coulthard S. A., 2001, Pharmacogenomics Journal, V1, P254
[6]
de la Moureyre CSV, 1999, PHARMACOGENETICS, V9, P189
[7]
Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine [J].
Evans, WE ;
Hon, YY ;
Bomgaars, L ;
Coutre, S ;
Holdsworth, M ;
Janco, R ;
Kalwinsky, D ;
Keller, F ;
Khatib, Z ;
Margolin, J ;
Murray, J ;
Quinn, J ;
Ravindranath, Y ;
Ritchey, K ;
Roberts, W ;
Rogers, ZR ;
Schiff, D ;
Steuber, C ;
Tucci, F ;
Kornegay, N ;
Krynetski, EY ;
Relling, MV .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2293-2301
[8]
Polymorphism of the thiopurine S-methyltransferase gene in African-Americans [J].
Hon, YY ;
Fessing, MY ;
Pui, CH ;
Relling, MV ;
Krynetski, EY ;
Evans, WE .
HUMAN MOLECULAR GENETICS, 1999, 8 (02) :371-376
[9]
Hongeng S, 2000, MED PEDIATR ONCOL, V35, P410, DOI 10.1002/1096-911X(20001001)35:4<410::AID-MPO3>3.0.CO
[10]
2-R